People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ashvattha Therapeutics, LLC | — | Biotechnology | Series C | $61.3M | $1.8B | 2021 |
| CoRISMA MCS Systems, Inc. | — | Biotechnology | Series A | $5.2M | $112.0M | 2021 |
Yuhang Zhao at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yuhang Zhao on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jay Zaveri | 1 | 5 |
| JEFFREY CLELAND | 1 | 4 |
| JUSTIN HANES | 1 | 3 |
| George Montgomery | 1 | 2 |
| Sujatha Kannan | 1 | 1 |
| Kannan Rangaramanujam | 1 | 1 |
| Barbara Slusher | 1 | 1 |
| Michael Theran | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.